Retina news in 2017 included anti-VEGF developments and clinical trial updates for a number of new drugs for a variety of indications.
Here are the top 10 most read retina articles on Healio.com/OSN in 2017:
1. Brolucizumab shows noninferiority to aflibercept for treatment of AMD
Two phase 2 studies comparing brolucizumab vs. aflibercept for the treatment of neovascular age-related macular degeneration showed comparable efficacy results at 40 weeks of follow-up. Read more.
2. Lampalizumab reduces geographic atrophy lesion progression
Monthly lampalizumab, a potential therapy for